The prognostic significance of proliferative indices in surgically resected IIIA-N2 non-small cell lung cancer after induction chemotherapy

被引:2
作者
Corzani, Roberto [1 ]
Luzzi, Luca [1 ]
Spina, Donatella [2 ]
Voltolini, Luca [1 ]
Paladini, Piero [1 ]
Ghiribelli, Claudia [1 ]
Ghisalberti, Marco [1 ]
Borrelli, Roberto [1 ]
Meniconi, Fabiola [1 ]
Monaci, Nicola [1 ]
Gotti, Giuseppe [1 ]
机构
[1] Univ Hosp Siena, Dept Thorac Surg, Siena, Italy
[2] Univ Hosp Siena, Human Pathol, Siena, Italy
关键词
Carcinoma; Non-Small-Cell Lung; Therapy; Surgery; Apoptosis; Mitosis; Prognosis; STAGE IIIA; SURGERY; TRIAL; RADIOCHEMOTHERAPY; GUIDELINES;
D O I
10.23736/S0021-9509.16.08232-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The aim of this study was to assess the prognostic significance of Mib1 expression, Mitosis (Mi) and Apoptosis (Ai) in residual tumour cells after induction chemotherapy in surgically resected IIIA-N2 patients. METHODS: Between January 2002 and November 2008, we reviewed 50 consecutive patients (39 males) with histologically proven stage IIIAN2 non-small cell lung cancer (NSCLC), who underwent radical resection following induction chemotherapy. Five-year survival in the series was evaluated in relation to lymph node downstaging, histology, extent of resection, number of chemotherapy cycles, pT status, sex and age. It was then also evaluated in relation to the proliferative indexes (Mi, Ap and Mib 1 expression), dividing the patients into two groups according to whether they were above or below the 50th percentile for each parameter. The associations between mortality and the abovementioned prognostic factors were explored using the Kaplan-Meier method, the log-rank test, and Cox regression analysis. RESULTS: The monovariate analysis confirmed the positive prognostic role of lymph node downstaging in terms of 5-yr survival: 31% vs. 12% (P=0.018). However Mi and Mib1 expression under the 50th percentile were also associated with better 5-yr survival: respectively 46% vs. 5% (P=0.007) and 40% vs. 6% (P=0.017). Neither apoptosis nor the other prognostic factors showed any statistical impact on long-term survival. The multivariate analysis showed Mi to be an independent prognostic factor (P=0.005). CONCLUSIONS: Although lymph node downstaging has been considered the principal prognostic factor after induction chemotherapy and surgical resection, Mi and Mib1 expression in residual tumor can predict long-term survival more accurately.
引用
收藏
页码:763 / 769
页数:7
相关论文
共 22 条
  • [1] Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial
    Albain, Kathy S.
    Swann, R. Suzanne
    Rusch, Valerie W.
    Turrisi, Andrew T., III
    Shepherd, Frances A.
    Smith, Colum
    Chen, Yuhchyau
    Livingston, Robert B.
    Feins, Richard H.
    Gandara, David R.
    Fry, Willard A.
    Darling, Gail
    Johnson, David H.
    Green, Mark R.
    Miller, Robert C.
    Ley, Joanne
    Sause, Willliam T.
    Cox, James D.
    [J]. LANCET, 2009, 374 (9687) : 379 - 386
  • [2] CONCURRENT CISPLATIN/ETOPOSIDE PLUS CHEST RADIOTHERAPY FOLLOWED BY SURGERY FOR STAGES IIIA(N2) AND IIIB NON-SMALL-CELL LUNG-CANCER - MATURE RESULTS OF SOUTHWEST-ONCOLOGY-GROUP PHASE-II STUDY-8805
    ALBAIN, KS
    RUSCH, VW
    CROWLEY, JJ
    RICE, TW
    TURRISI, AT
    WEICK, JK
    LONCHYNA, VA
    PRESANT, CA
    MCKENNA, RJ
    GANDARA, DR
    FOSMIRE, H
    TAYLOR, SA
    STELZER, KJ
    BEASLEY, KR
    LIVINGSTON, RB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) : 1880 - 1892
  • [3] Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival
    Bueno, R
    Richards, WG
    Swanson, SJ
    Jaklitsch, MT
    Lukanich, JM
    Mentzer, SJ
    Sugarbaker, DJ
    [J]. ANNALS OF THORACIC SURGERY, 2000, 70 (06) : 1826 - 1831
  • [4] The treatment of patients with stage IIIA non-small cell lung cancer from N2 disease: Who returns to the surgical arena and who survives
    Cerfolio, Robert J.
    Maniscalco, Lee
    Bryant, Ayesha S.
    [J]. ANNALS OF THORACIC SURGERY, 2008, 86 (03) : 912 - 920
  • [5] ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer
    De Leyn, Paul
    Lardinois, Didier
    Van Schil, Paul E.
    Rami-Porta, Ramon
    Passlick, Bernward
    Zielinski, Marcin
    Walter, David A.
    Lerut, Tony
    Weder, Walter
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2007, 32 (01) : 1 - 8
  • [6] The role of surgery in N2 non-small cell lung cancer
    DeCamp, MM
    Ashiku, S
    Thurer, R
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5033S - 5037S
  • [7] Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: A model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography
    Dooms, Christophe
    Verbeken, Eric
    Stroobants, Sigrid
    Nackaerts, Kris
    De Leyn, Paul
    Vansteenkiste, Johan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1128 - 1134
  • [8] Surgery for patients with persistent pathological N2 IIIA stage in non-small-cell lung cancer after induction radio-chemotherapy: the microscopic seed of doubt
    Meacci, Elisa
    Cesario, Alfredo
    Cusumano, Giacomo
    Lococo, Filippo
    D'Angelillo, Rolando
    Dall'Armi, Valentina
    Margaritora, Stefano
    Granone, Pierluigi
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 40 (03) : 656 - 663
  • [9] Revisions in the International System for Staging Lung Cancer
    Mountain, CF
    [J]. CHEST, 1997, 111 (06) : 1710 - 1717
  • [10] Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: Age, mediastinal downstaging, and extent of pulmonary resection as independent predictors
    Paul, Subroto
    Mirza, Farooq
    Port, Jeffrey L.
    Lee, Paul C.
    Stiles, Brendon M.
    Kansler, Amanda L.
    Altorki, Nasser K.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2011, 141 (01) : 48 - 58